Sirtex Medical Limited

Sirtex Medical is a global healthcare business with offices in the U.S., Australia, Germany and Singapore, working to improve outcomes in people with cancer. Our current lead product is a targeted radiation therapy for liver cancer called SIR-Spheres® Y-90 resin microspheres.
More than 100,000 doses have been supplied to treat patients with liver cancer at more than 1,300 medical centers in over 50 countries.

Together the team at Sirtex is introducing innovative new therapies that promise to improve the lives of people around the world facing the challenges of cancer.

Our ongoing success is based on our commitment to serving our medical customers, professionalism, a collaborative working culture, an entrepreneurial spirit, continuous improvement and innovation.

We are dedicated to making Sirtex a great place to work and providing all our employees with a range of benefits, programs and services to ensure they have the opportunity to contribute to the success of our business and further their professional careers.

We are an equal opportunity employer.

For more information, visit www.sirtex.com and connect with us on Twitter and Facebook.

SIR-Spheres® is a registered trademark of Sirtex SIR-Spheres Pty Ltd